GlassScriptPhysician profile
Bridget B Peterson
NPI 1215908462
$1,486.53
in general payments reported to CMS, 2019-2025
18 companies · $40.19 in 2025
The $40.19 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $588 · 2022: $303 · 2023: $298 · 2024: $258 · 2025: $40.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.83 |
| Education | $182.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $321.94 | 2021-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Abbvie INC. | $194.26 | 2021-2024 | |
| Abbott Laboratories | $192.19 | 2021-2023 | Freestyle Libre 3 |
| Janssen Biotech, INC. | $95.00 | 2024 | Darzalex |
| Incyte Corporation | $87.99 | 2024 | |
| Amgen INC. | $86.51 | 2021-2023 | Repatha |
| Novo Nordisk INC | $80.42 | 2021-2023 | |
| Xeris Pharmaceuticals, INC. | $76.13 | 2021-2022 | |
| Inspire Medical Systems, INC. | $72.94 | 2023-2024 | Inspire |
| Amarin Pharma, INC. | $69.07 | 2021 | |
| Novartis Pharmaceuticals Corporation | $56.08 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $40.19 | 2025 | Rexulti |
| Astellas Pharma US INC | $36.17 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $20.38 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.06 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $14.04 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.03 | 2021 | |
| Lilly USA, LLC | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.